<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>121257808 &#8211; Canyon Crest Guide Local News</title>
	<atom:link href="https://canyoncrestguide.com/tag/121257808/feed/" rel="self" type="application/rss+xml" />
	<link>https://canyoncrestguide.com</link>
	<description>Canyon Crest News</description>
	<lastBuildDate>Mon, 28 Apr 2025 23:37:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://canyoncrestguide.com/wp-content/uploads/2023/08/Canyon-Crest-Guide-Local-News-100x100-1-65x65.jpeg</url>
	<title>121257808 &#8211; Canyon Crest Guide Local News</title>
	<link>https://canyoncrestguide.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Immunotherapy drug capable of eliminating tumors in some early-stage cancers: Study</title>
		<link>https://canyoncrestguide.com/immunotherapy-drug-capable-of-eliminating-tumors-in-some-early-stage-cancers-study/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Mon, 28 Apr 2025 23:37:03 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[121257808]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[cancers]]></category>
		<category><![CDATA[capable]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[earlystage]]></category>
		<category><![CDATA[eliminating]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[tumors]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/immunotherapy-drug-capable-of-eliminating-tumors-in-some-early-stage-cancers-study/</guid>

					<description><![CDATA[[ad_1] A new study in the New England Journal of Medicine suggests that some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab. In the study, 82 out of 103 participants responded so well to the drug that they no longer needed an operation. The Memorial [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
